BarouchLab Profile Banner
Barouch Lab Profile
Barouch Lab

@BarouchLab

Followers
2K
Following
2K
Media
79
Statuses
400

Science from the Dan Barouch Lab at @BIDMCHealth and @harvardmed’s Center for Virology & Vaccine Research. RTs ≠ endorsements

Boston, MA
Joined July 2020
Don't wanna be here? Send us removal request.
@BarouchLab
Barouch Lab
2 years
New data from the Barouch Lab on BA.2.86. 1. NAb responses to BA.2.86 were lower than to BA.2 but were comparable or higher than to current circulating variants. 2. NAb titers to all variants including BA.2.86 increased following XBB infection
Tweet media one
22
110
350
@BarouchLab
Barouch Lab
9 days
RT @angie_rasmussen: Beautiful paper from @BarouchLab looking at H5N1 pathogenesis in rhesus & cynomolgus macaques (link in replies). Dan p….
0
7
0
@grok
Grok
2 days
Join millions who have switched to Grok.
46
73
610
@BarouchLab
Barouch Lab
2 months
RT @LabWaggoner: Mucosal delivery and gene-based vaccines can both enhance boost responses for influenza vaccination in cynomolgus macaques….
0
1
0
@BarouchLab
Barouch Lab
2 months
RT @ScienceTM: mRNA or adenovirus flu vaccine boosters produce strong immune responses against H1N1 and match the efficacy of a live-attenu….
0
2
0
@BarouchLab
Barouch Lab
5 months
RT @lasradoN: #LongCovid has impaired millions of people, with no cure on the horizon. @BIDMC_CVVRTrial has launched a trial to test Abroci….
0
8
0
@BarouchLab
Barouch Lab
5 months
Email BIDMC-CVVRTRIALS@bidmc.harvard.edu or call 617-735-4610 to inquire. Additional information can also be found here [. (2/2).
0
4
3
@BarouchLab
Barouch Lab
5 months
Long COVID or PASC may be characterized by persistent activation of chronic inflammatory pathways, affecting millions of Americans. Our latest clinical trial focuses on repurposing Abrocitinib to reduce symptoms in people with Long COVID. Our trial is currently recruiting! (1/2)
Tweet media one
3
14
23
@BarouchLab
Barouch Lab
10 months
RT @lasradoN: It took some time for this to come out, but I am glad it's out now @ScienceTM!!! It was a huge effort by our team @BarouchLab….
Tweet card summary image
science.org
COVID-19 mRNA booster vaccines induce limited mucosal immunity.
0
10
0
@BarouchLab
Barouch Lab
11 months
RT @JAMA_current: This study shows that mpox antibody responses generated by the MVA-BN vaccine wane significantly within 6 to 12 months, p….
0
5
0
@BarouchLab
Barouch Lab
11 months
RT @BIDMC_Research: New data from @BIDMChealth @BarouchLab suggests that protective immunity against #Mpox may have waned in previously va….
0
3
0
@BarouchLab
Barouch Lab
1 year
RT @jiasociety: Ahead of #HIVVaccineAwarenessDay JIAS has published a new viewpoint, “The potential of broadly neutralizing antibodies for….
0
5
0
@BarouchLab
Barouch Lab
1 year
A new Covid variant has taken over, and experts predict a small summer wave
1
9
6
@BarouchLab
Barouch Lab
1 year
RT @irmdirector: Join us on April 25 for the #HIRM 10 Year Anniversary #RNA Medicine Symposium feat. Dr. Dan Barouch, MD, PhD Director of t….
0
1
0
@BarouchLab
Barouch Lab
1 year
Tweet media one
0
0
1
@BarouchLab
Barouch Lab
1 year
RT @ScienceTM: A new head-to-head comparison of approved #mpox vaccines and vaccine candidates sheds light on their protective efficacy, an….
0
4
0
@BarouchLab
Barouch Lab
1 year
RT @LabWaggoner: MVA and multivalent Ad35-based vaccines induced robust protection against Mpox challenge in nonhuman primates, whereas ACA….
0
1
0
@BarouchLab
Barouch Lab
1 year
RT @lasradoN: Our new brief report on the neutralization of Omicron subvariant BA.2.87.1 is now out on @Els_Vaccine! A great and rapid team….
0
41
0
@BarouchLab
Barouch Lab
2 years
RT @lasradoN: Our new paper on immunity of bivalent mRNA boosters and IgG profiling, especially IgG4 responses after 3rd and 4th mRNA vacci….
Tweet card summary image
science.org
Bivalent COVID-19 mRNA boosting induced limited durability of NAbs and primarily IgG4 responses with poor functionality.
0
4
0
@BarouchLab
Barouch Lab
2 years
“We are not going to be able to completely stop transmission, and we’re not going to be able to get rid of this virus in the human population,” said Dr. Dan Barouch. Click the link to read the full article:.
Tweet media one
0
0
1
@BarouchLab
Barouch Lab
2 years
mRNA vaccines against SARS-CoV-2 induce divergent antigen-specific T-cell responses in patients with lung cancer
Tweet media one
1
1
7